Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Hepatitis × Methylprednisolone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leukemia 31 Lymphoma 25 Precursor Cell Lymphoblastic Leukemia-Lymphoma 24 Burkitt Lymphoma 23 Lymphoma, Non-Hodgkin 20 Lymphoma, Large B-Cell, Diffuse 20 Myelodysplastic Syndromes 18 Leukemia, Myeloid, Chronic-Phase 17 Lymphoma, Follicular 16 Leukemia, Lymphocytic, Chronic, B-Cell 15 Multiple Myeloma 14 Leukemia, Myeloid, Accelerated Phase 14 Blast Crisis 14 Lymphoma, Large-Cell, Immunoblastic 13 Dendritic Cell Sarcoma, Interdigitating 13 Recurrence 12 Myeloproliferative Disorders 12 Leukemia, Myeloid, Acute 12 Leukemia, Myelomonocytic, Chronic 11 Graft vs Host Disease 11 Lymphoma, Mantle-Cell 10 Lymphoma, B-Cell, Marginal Zone 10 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 10 Neoplasms, Plasma Cell 9 Myelodysplastic-Myeloproliferative Diseases 8 Leukemia, Myelomonocytic, Juvenile 8 Hodgkin Disease 8 Congenital Abnormalities 8 Primary Myelofibrosis 7 Lymphoma, Large-Cell, Anaplastic 7

Interventions

Ursodeoxycholic Acid 1 Steroids 1 Sofosbuvir 1 Ribavirin 1 Prednisone 1 Mycophenolic Acid 1 Methylprednisolone Hemisuccinate 1 Methylprednisolone 1 Adrenal Cortex Hormones 1 3-(2-(2-tert-butylphenylaminooxalyl)aminopropionylamino)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04810156 2022-12-14

I-HEP

Herlev Hospital

Phase 2 Unknown

Hepatitis, Neoplasms, Chemical and Drug Induced Liver Injury

Data powered by HemOnc (CC BY 4.0) Colophon ⚡